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Abstract. 
 
Mice carrying the 
 
Tight skin
 
 (
 
Tsk
 
) mutation 
harbor a genomic duplication within the fibrillin-1 (
 
Fbn 
1
 
) gene that results in a larger than normal in-frame 
 
Fbn 1
 
 transcript. In this study, the consequences of the 
 
Tsk
 
 mutation for fibrillin-containing microfibrils have 
been examined. Dermal fibroblasts from 
 
Tsk
 
/
 
1
 
 mice 
synthesized and secreted both normal fibrillin (
 
z
 
330 
kD) and the mutant oversized 
 
Tsk
 
 fibrillin-1 (
 
z
 
450 kD) 
in comparable amounts, and 
 
Tsk
 
 fibrillin-1 was stably 
incorporated into cell layers. Immunohistochemical 
and ultrastructural analyses of normal and 
 
Tsk
 
/
 
1
 
 
mouse skin highlighted differences in the gross organi-
zation and distribution of microfibrillar arrays. Rotary 
shadowing of high 
 
M
 
r
 
 preparations from 
 
Tsk
 
/
 
1
 
 skin 
demonstrated the presence of abundant beaded mi-
crofibrils. Some of these had normal morphology and 
periodicity, but others were distinguished by diffuse in-
terbeads, longer periodicity, and tendency to aggregate. 
The presence of a structurally abnormal population of 
microfibrils in 
 
Tsk
 
/
 
1
 
 skin was unequivocally demon-
strated after calcium chelation and in denaturating con-
ditions. Scanning transmission electron microscopy 
highlighted the presence of more mass in 
 
Tsk
 
/
 
1
 
 skin 
microfibrils than in normal mice skin microfibrils. 
These data indicate that 
 
Tsk
 
 fibrillin-1 polymerizes 
and becomes incorporated into a discrete population 
of beaded microfibrils with altered molecular organi-
zation.
T
 
he 
 
glycoprotein fibrillin-1 is the major structural
protein of a widely distributed class of connective
tissue microfibrils that are key components of elas-
tic fibers (3, 23, 33, 34). The primary structure of fibrillin-1
predicts a 
 
M
 
r
 
 of 312,000 and a complex multidomain orga-
nization (4, 26). It contains 47 epidermal growth factor–
like domains, 43 of which have calcium-binding consensus
sequences (cbEGF
 
1
 
-like domains), 9 8-cysteine repeats, a
proline-rich region that may act as a hinge, and unique
amino- and carboxy-terminal sequences. Recently, a ge-
nomic duplication of 30–40 kb within the mouse 
 
fibrillin 1
 
(
 
Fbn 1
 
) gene was described in association with the mouse
 
Tight skin
 
 (
 
Tsk
 
) phenotype (37). This mutation results in a
mutant transcript that is 3 kb larger than the wild-type
transcript, contains an in-frame duplication of exons 17–
40, and is predicted to encode a mutant fibrillin-1 polypep-
tide of 
 
M
 
r
 
 418,000. The mutant molecule would have an
additional Arg-Gly-Asp (RGD) cell recognition sequence,
two and one-third additional 8-cysteine repeats, 18 addi-
tional cbEGF-like domains, and one extra hybrid 8-cys-
teine motif, in comparison to the wild-type fibrillin-1 pro-
tein.
The phenotype of heterozygous 
 
Tsk
 
/
 
1
 
 mice includes
thickened skin and visceral fibrosis resulting from accumu-
lation of extracellular matrix (10). The skin adheres firmly
to the hyperplastic subcutaneous tissues, lacks the pliabil-
ity and elasticity of normal skin, and exhibits altered
wound healing properties. Other features include increased
bone and cartilage growth, lung emphysema, myocardial
hypertrophy, and the presence of small tendons with ten-
don sheath hyperplasia (7, 21, 31). Large accumulations of
microfibrils, several collagens, and glycosaminoglycans
have been identified in various 
 
Tsk
 
/
 
1
 
 organs including
skin, heart, and lungs (10, 13, 14). Homozygous 
 
Tsk
 
 em-
bryos degenerate at 7 or 8 d of development, whereas het-
erozygous mice have a normal life span. The 
 
Tsk
 
 mouse
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has been used as a model for several human diseases, in-
cluding cardiac hypertrophy (15, 25), hereditary emphy-
sema (7, 22, 32) and systemic sclerosis or scleroderma (15).
The 
 
Tsk
 
 phenotype may arise as a direct consequence of
microfibril structural defects resulting from the mutation
in 
 
Fbn 1
 
 and/or by alterations in cellular activity induced
by the mutation. Comparable steady-state levels of normal
and mutant 
 
Fbn 1
 
 transcripts in 
 
Tsk
 
/
 
1
 
 tissues (37) and
abundant amounts of tissue microfibrils (10) suggest that
mutant 
 
Tsk
 
 fibrillin-1 is synthesized and assembled. The
disorganization and fragmentation of 
 
Tsk
 
/
 
1
 
 elastic fibers
(7) may reflect structurally abnormal microfibrils.
Rotary shadowing analyses of fibrillin-containing mi-
crofibrils have demonstrated pronounced beaded domains
connected by filamentous interbead regions, a regular di-
ameter of 10–12 nm, and an average axial periodicity, in
relaxed isolated state of 50–56 nm (17, 18, 36). Polymer-
ized fibrillin forms the structural framework of microfibrils,
but key details that remain outstanding are the arrange-
ment of fibrillin monomers within microfibrils and the mo-
lecular basis of microfibril diameter, periodicity, and extensi-
bility. The purpose of this study was to demonstrate the
synthesis of abnormal mutated fibrillin-1 molecules in 
 
Tsk
 
/
 
1
 
mice and to examine their incorporation into skin micro-
fibrils to generate new insights into microfibril assembly and
organization.
 
Materials and Methods
 
Materials
 
Bacterial collagenase (type 1A), PMSF, 
 
N
 
-ethylmaleimide (NEM), benza-
midine, guanidinium chloride (GuHCl), protein A–Sepharose colloidal
gold conjugate, protein A–Sepharose, and Triton X-100 were obtained
from Sigma Chemical Co. (Poole, Dorset, UK). Sepharose CL-2B was
supplied by Pharmacia-LKB (Milton Keynes, Bucks, UK). MultiMark™
SDS-PAGE molecular weight markers were supplied by Novex (San Di-
ego, CA). Normal donkey serum and Texas red were purchased from
Jackson ImmunoResearch (West Grove, PA), and Mowiol was purchased
from Hoechst, (Frankfurt-Hoechst, Germany). 
 
35
 
[S]cys/met Translabel
and 
 
45
 
CaCl
 
2
 
 was obtained from ICN Biomedicals, Inc., (Meckenheim,
Germany). Chelex 100 was obtained from (Bio-Rad Laboratories, Her-
cules, CA). The antifibrillin antisera used were a polyclonal antibody
(9022) raised to fibrillin-1 PF2 fragment (20) that was kindly provided by
R. Glanville (Shriner’s Hospital, Portland, OR) and a polyclonal antibody
(5077) raised to intact microfibrils (17, 20, 27).
 
Mice
 
Mice of the C57BL/6-
 
pa
 
 
 
1
 
/
 
1
 
Tsk
 
 genotype were originally purchased
from Jackson Laboratory (Bar Harbor, ME). The 
 
Tsk
 
 mutation was trans-
ferred onto the C57BL/6J (B6) background by sequential backcrossing at
the Jefferson Medical College (Philadelphia, PA). The B6-
 
Tsk
 
/
 
1
 
 and B6-
 
1
 
/
 
1
 
 mice used for these studies were at the N6 generation. The mutant
 
Tsk
 
 phenotype was determined by manual assessment of the thickness
and tightness of the skin in the intercapsular region as well as by Southern
blot analyses to distinguish the presence or absence of the duplicated re-
gion of the 
 
Fbn 1
 
 gene (37).
 
Biosynthesis and Radioimmunoprecipitation of Fibrillin
 
Dermal fibroblasts were established from normal and 
 
Tsk
 
/
 
1
 
 mice and
were seeded at a density of 5 
 
3
 
 10
 
5
 
 per 35-mm dish after passage. When
confluent, the cultures were either labeled continuously in the presence of
100 
 
m
 
Ci of 
 
35
 
[S]cys/met per 0.5ml cys- and met-free minimal essential me-
dium per well for 17 h, or pulse labeled with 100 
 
m
 
Ci 
 
35
 
[S]cys/met for 60
min, and then chased for 24 h. Fibrillin was radioimmunoprecipitated
from the continuously labeled culture medium, which was preabsorbed
with normal rabbit serum and protein A–Sepharose overnight at 4
 
8
 
C. Af-
ter removal of Sepharose beads, the media were incubated with the PF2
antibody or normal rabbit serum (25 
 
m
 
l per 0.5-ml aliquot) for 19 h at 4
 
8
 
C.
Immune complexes were adsorbed to a suspension of 50 
 
m
 
l of protein
A–Sepharose for 2 h at room temperature and then washed three times in
radioimmunoprecipitation assay buffer. The bound proteins were released
by boiling in 75 
 
m
 
l of double-strength sample buffer containing 10%
 
b
 
-mercaptoethanol. Proteins were separated on 4% SDS-PAGE gels. Ali-
quots of crude medium were added to equal volumes of double-strength
sample buffer and then analyzed on the same gel (27).
 
Confocal Laser Scanning Immunolabeling Analysis
 
Cryostat sections (7 
 
m
 
m) of normal and 
 
Tsk
 
/
 
1
 
 mice skin were fixed in ace-
tone for 10 min. Nonspecific binding sites were blocked by incubation
with 10% normal donkey serum/1% BSA in PBS for 30 min at room tem-
perature. This step was followed by incubation in primary antibody (PF2
antibody or 5507; 1:100 in PBS) overnight at room temperature. Bound
antibody was visualized using a 1:100 dilution of donkey Fab2 against rab-
bit IgG coupled to Texas red for 30 min at room temperature. Prepara-
tions were mounted in Mowiol in 0.01 M Tris-HCl, pH 8.6. Preparations
were examined using an invert device (model LSM 410; Carl Zeiss, Inc.,
Oberkochen, Germany). A 40-fold oil immersion objective (numerical ap-
erture 1.3) was used. Single optical sections (0.6–0.7 
 
m
 
m) were obtained with
identical scanning settings and excitation conditions to distinguish differ-
ences in fluorescence intensities between 
 
Tsk
 
/
 
1
 
 and normal mouse skin.
 
Transmission Electron Microscopy
 
Skin biopsies were minced, fixed in 2.5% glutaraldehyde in 100 mM ca-
codylate, pH 7.2, for 48 h, osmicated en bloc, and then embedded in Epon
812 (Polysciences Inc., Warington, PA). Ultrathin sections were counter-
stained with uranyl acetate and lead citrate and then viewed with an elec-
tron microscope (model EM 401; Philips Electron Optics, Eindhoven, The
Netherlands) at an accelerating voltage of 60 kV.
 
Isolation of Intact Fibrillin-containing Microfibrils
 
Triplicate preparations of intact native microfibrils were isolated from
normal and 
 
Tsk
 
/
 
1
 
 mouse skin using a well-defined methodology (17, 19,
36). Briefly, tissues were disrupted by bacterial collagenase digestion in
0.05 M Tris-HCl, pH 7.4, containing 0.4 M NaCl and 0.01 M CaCl
 
2
 
 in the
presence of proteinase inhibitors (5 mM PMSF, 2 mM NEM, 5 mM benza-
midine). Microfibrils were isolated as high 
 
M
 
r
 
 assemblies in the void vol-
ume of a Sepharose CL-2B gel filtration chromatography column (15 
 
3
 
 1
cm; Pharmacia Biotech Ltd., Herts, UK). All microfibril preparations
were examined directly by rotary shadowing–electron microscopy and
scanning transmission electron microscopy (STEM). Microfibrils were in-
cubated for various lengths of time at 20
 
8
 
C in 5 mM EDTA or 5 mM
CaCl
 
2
 
, or at 37
 
8
 
C in 4 M GuHCl.
 
Enzymatic Digestion of Microfibrils
 
A suspension of intact microfibrils was equilibrated in 0.025 M Tris-HCl,
pH 7.4, containing 0.2 M NaCl with or without 5 mM EDTA and then in-
cubated for 2 or 18 h at 37
 
8
 
C in the presence of trypsin (Sigma Chemical
Co.) (1 
 
m
 
g:100 
 
m
 
l) or neutrophil elastase (gift from D. Woolley, University
of Manchester, Manchester, UK) (100 ng:100 
 
m
 
l). Consequences for mi-
crofibril integrity were monitored by rotary shadowing.
 
Rotary Shadowing–Electron Microscopy
 
Preparations of intact microfibrils were adsorbed directly onto carbon-
coated grids (2–3-nm film thickness) and metal shadowed with a tungsten/
platinum filament at an angle of 4
 
8
 
 (17, 36). Grids were visualized using an
electron microscope (model 1200EX; JEOL USA, Inc., Peabody, MA) at
an accelerating voltage of 100 kV.
 
STEM
 
STEM mass analysis is a well-established technique that has provided
quantitative data on mass per unit length and axial mass distribution on
unstained and unshadowed fibrillin-containing microfibrils and other
macromolecules (11, 12, 24, 35, 36). Preparations of intact native mi-
crofibrils were analyzed by STEM in a JEOL 1200EX transmission elec-
tron microscope as previously described (36). Mean axial repeat measure-
ments for each microfibril preparation were calculated from 40–50 axial
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repeat measurements across 10–30 periods per microfibril, with an error
of 
 
6
 
0.34%. Five measurements of mass per unit length were taken per mi-
crofibril, with 40–50 microfibrils per grid examined. Axial mass distribu-
tions were averages involving 10 measurements per microfibril. In all
cases, these STEM measurements were repeated on triplicate prepara-
tions. The axial repeat was the distance from the beginning of one bead to
the beginning of the next (effectively one bead plus one interbead do-
main). Analysis of variance analysis of axial repeat, mass per unit length,
and total mass per axial repeat data was performed.
 
Results
 
Synthesis and Secretion of Fibrillin-1 by Tsk/
 
1
 
Dermal Fibroblasts
 
Metabolic labeling of normal mouse dermal fibroblasts
and subsequent SDS-PAGE under reducing conditions re-
vealed a single protein band of 
 
z
 
330 kD that comigrated
with fibrillin from normal human fibroblasts (data not
shown) and was identified by the PF2 antibody (Fig. 1 
 
A
 
).
In contrast, the 
 
Tsk
 
/
 
1
 
 dermal fibroblast culture medium
contained an additional protein of 
 
z
 
450 kD that was also
recognized by these antibodies and was therefore identi-
fied as the gene product of the larger mutant 
 
Tsk Fbn 1
 
 gene.
Bands corresponding to normal and 
 
Tsk
 
 fibrillin-1 in the
Tsk/1 fibroblast radioimmunoprecipitates were of compa-
rable intensity. No specific protein bands were immuno-
precipitated with normal rabbit serum. Pulse-chase analy-
sis revealed that Tsk fibrillin-1 could be recovered from
the extracellular matrix of the fibroblast cultures (Fig. 1 B).
Confocal Laser and Transmission Electron Microscopy 
Analysis of Fibrillin-1 in Tsk/1 Mice Skin
A confocal laser scanning analysis of immunostaining of
the cutaneous microfibrillar network appeared substan-
tially more intense in the Tsk/1 skin than in the normal
mouse with the PF2 antibody, and far more details of this
structure were discernible (Fig. 2 A). In contrast, the anti-
body 5507 immunostained microfibrils in both normal and
mutant mice, but the immunostaining intensity was lower
in the Tsk/1 mouse under identical scanning conditions
(Fig. 2 B). This difference was most pronounced with the
microfibrils around hair follicles.
A transmission electron microscopy study revealed that,
in comparison with normal mice, Tsk/1 mice skin had
more prominent microfibrillar “clusters” in the upper der-
mis, although there was a noticable absence of well-
packed elastic fibrils with very electron-dense cores (Fig.
3). Tsk/1 mouse microfibrils, with or without associated
elastin, frequently appeared blurred without a discernible
striated pattern. The elastin appeared less electron dense
and less compact than those in samples from normal animals.
Examination of Microfibrils Isolated from Tsk/1
Mice Skin
Ultrastructure. Abundant beaded microfibrils were iso-
lated from littermate pairs of normal and Tsk/1 mice skin
(Fig. 4, A and B). Microfibrils from normal mouse skin
were well-organized linear arrays (Fig. 4 A). Some mi-
crofibrils isolated from Tsk/1 skin were morphologically
similar to those of the normal animals, but many other
Tsk/1 skin microfibrils were abnormal periodic arrays of
beads with indistinct filamentous interbeads and extended
periodicity (Fig. 4 B). The axial periodicity of control mice
microfibrils and the apparently normal population of mi-
crofibrils in Tsk/1 preparations was 55 6 4 nm, which is
comparable to previously published dimensions of mi-
crofibrils from other sources (18, 36). However, the abnor-
mal Tsk/1 skin microfibrils had a more extended bead-
to-bead distance of 112 6 11 nm. The number of normal
and abnormal microfibrils in triplicate Tsk/1 skin prepa-
rations was counted in 200 low-magnification (5,0003)
fields; this analysis indicated that the abnormal microfibrils
represented 45 6 10% of the total microfibril population.
Aggregates. Extensive microfibril clusters were also pre-
sent in the Tsk/1 skin preparations, but not in those from
normal skin (Fig. 5, A and B). In these aggregates, intermi-
crofibril filaments were apparent.
STEM Mass Analysis. STEM mass analysis in dark field
of normal and Tsk/1 skin microfibrils detected a signifi-
cant mass increase in the Tsk/1 skin microfibril popula-
tion. Total mass per axial repeat for the normal skin mi-
crofibrils was 2,547 kD, whereas that for the abnormal
Tsk/1 skin microfibrils was 3,074 kD, an average increase
of 527 kD per axial repeat.
Stability of Tsk/1 Skin Microfibrils
Structural Response to Calcium Chelation. Rotary shadow-
ing examination of normal mouse skin microfibrils incu-
Figure 1. (A) SDS-PAGE
analysis of newly synthesized
fibrillin-1 radioimmunopre-
cipitated from medium of
normal and Tsk/1 dermal fi-
broblast cultures. Newly syn-
thesized, labeled fibrillin-1
was radioimmunoprecipitated
from the medium of dermal
fibroblasts that had been la-
beled with 35[S]cys/met for
17 h. Tsk/1 cells synthesized
and then secreted both nor-
mal (z330 kD) and Tsk
fibrillin-1 (z450 kD) in com-
parable amounts. Lanes 1, 3
and 5, medium from normal
mice cells; lanes 2, 4, and 6,
medium from Tsk/1 mice
cells. Lanes 1 and 2, crude
medium; lanes 3 and 4, fibril-
lin-1 immunoprecipitated with
PF2 antiserum; lanes 5 and 6,
immunoprecipitation controls
using normal rabbit serum.
(B) Incorporation of the over-
sized Tsk monomer into ex-
tracellular matrix. Normal and
Tsk fibroblast cultures were
pulsed for 1 h with 35[S]met/
cys and chased in culture medium containing 2% fetal calf serum
for 24 h. Medium and extracellular matrix extracts were har-
vested after this period of time. The medium and extracellular
matrix of both cell cultures contains the normal fibrillin (z330
kD). (small arrow). In addition, medium and extracellular matrix
of the Tsk cell strain contain the oversized fibrillin-1 monomer
(z450 kD; large arrow).
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bated in the presence of 5 mM EDTA for 10 min demon-
strated they had reduced periodicity (38 6 2 nm), prominent
beads, and a diffuse interbead appearance as previously
described (35) (Fig. 4 C). The morphologically normal mi-
crofibrils from Tsk/1 skin exhibited the same response as
the normal mouse skin microfibrils to calcium chelation
(Fig. 4 D). However, EDTA-induced changes in the ab-
normal Tsk/1 skin microfibril population were unequivo-
cally different from those of the apparently normal mi-
crofibrils (Fig. 4 D). Axial repeat distances in the abnormal
microfibrils were reduced to 61 6 3 nm, and beads did not
appear prominent, although interbeads became more in-
distinct. EDTA failed to disrupt the large Tsk/1 microfibril
aggregates that remained tightly associated but with less
well-defined intermicrofibril filaments (Fig. 5, C and D).
Effects of Chaotropic Agents. To study whether Tsk/1
mice skin microfibrils had altered stability, the effects of
chaotropic agents were assessed. 4 M GuHCl-treated nor-
mal mice skin microfibrils and the apparently normal Tsk/1
skin microfibrils underwent a conformational change simi-
lar to that observed for EDTA, with periodicities reduced
to 43.9 6 9.2 nm, although they remained beaded poly-
mers as previously reported for bovine microfibrils (36). In
contrast, the abnormal Tsk/1 microfibrils became disor-
dered networks with loss of overt periodicity (data not
shown).
Susceptibility to Enzymatic Digestion. In the presence of
calcium, microfibrils isolated from normal and Tsk/1 mice
were degraded to short, beaded arrays by trypsin or neu-
trophil elastase by 18 h. There were no obvious differences
in the susceptibility of the control mice microfibrils and
the morphologically normal Tsk/1 skin microfibrils to
degradation by either enzyme. Short arrays of normal and
abnormal Tsk/1 skin microfibrils were detected after di-
gestion, as judged by morphology (data not shown). When
EDTA-treated microfibrils were incubated with enzymes,
all microfibrils were rapidly degraded within 2 h, with only
beaded domains apparent.
Discussion
A previous study of Tsk mice demonstrated that a tandem
duplication within the Fbn 1 is associated with the mouse
Tsk mutation and established that the mutant allele is
transcribed in Tsk tissues (37). This investigation was un-
dertaken to study whether Tsk fibrillin-1 protein is pro-
duced and assembled, and if so, to examine the conse-
quences for microfibril organization.
The Tsk mutation is predicted to give rise to an over-
sized fibrillin-1 molecule with a calculated molecular mass
of 418 kD (37) and an expected presence of seven poten-
tial additional N-glycosylation sites. We demonstrate now
that cultured dermal fibroblasts of Tsk/1 mice synthesize
and secrete normal fibrillin-1 with an apparent molecular
mass of 330 kD and a fibrillin-1 molecule with an apparent
molecular mass of 450 kD in comparable amounts. The
electrophoretic behavior of Tsk fibrillin-1 was in accor-
dance with the predictions and confirmed full expression
Figure 2. Confocal laser scanning analysis of normal and Tsk/1 mice skin. (A) a and c, normal mouse skin; b and d, Tsk/1 mouse skin.
In the normal mouse, PF2 antibody stains the papillary microfibrillar apparatus beneath and along the basement membrane region,
perivascular microfibrils, and the surrounding microfibrillar matrix around hair follicles. The identical regions in the Tsk/1 mouse are
labeled, but in comparison with normal mouse skin, the intensity of the immune signal is substantially increased. Bar, 20 mm. (B) a and
c, normal mouse; b and d, Tsk/1 mouse. In the normal mouse, 5507 antibody strongly stains the papillary microfibrillar apparatus be-
neath the dermal–epidermal junction and the matrix surrounding the hair follicles. The same structures are immunolabeled in Tsk/1
skin, but the intensity is reduced. Bar, 20 mm.
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of the mutant protein. We have several lines of evidence
that this oversized molecule aggregates and is incorporated
into microfibrils.
Pulse-chase experiments confirmed the incorporation of
comparable levels of newly synthesized normal and over-
sized fibrillin-1 monomers into the extracellular matrix of
Tsk dermal fibroblast cultures. Confocal laser scanning
microscopy confirmed the presence of a cutaneous mi-
crofibrillar network in Tsk mice. Immunoreactivity differ-
ences to normal mice using antibodies raised to fibrillin-1
and to intact microfibrils could reflect altered microfibril
abundance, changed accessibility of fibrillin-1 epitopes,
and/or secondary extracellular matrix changes in affected
mice. The transmission electron microscopy study demon-
strated that Tsk/1 skin microfibrils were blurred in ap-
pearance with no obvious periodicity and limited elastin
deposition, indicating structural microfibrillar changes.
Ultrastructural examination of beaded microfibrils iso-
lated from Tsk/1 skin revealed clear evidence for two dis-
tinct microfibril populations, one composed of morpholog-
ically normal microfibrils, whereas the other population of
microfibrils was abnormal with diffuse interbeads and
longer than normal periodicity. No other microfibrils with
such structural characteristics have previously been dem-
onstrated from any tissue or cellular source. These obser-
vations indicate that the abnormal microfibrils compose
Tsk fibrillin-1 and have consequently altered molecular
organization. The dark-field STEM data demonstrating in-
creased mass of Tsk/1 skin microfibrils support this con-
clusion. The extra mass presumably reflects incorporation
Figure 3. Ultrastructural
study of normal and Tsk/1
mice skin. a, c, and e, normal
mouse; b, d, and f, Tsk/1
mouse. a and b are low-
power views (5,0003) show-
ing basal keratinocytes, the
dermo–epidermal junction
as represented by the lamina
densa (open arrows), and the
upper dermis. In both mice,
the dermis is dominated by
collagen bundles. Microfibril-
lar bundles and elastic fibers
are indicated by closed ar-
rows. b reveals the presence
of larger microfibrillar bun-
dles with abundant microfibrils
but little elastin. c–f are high
magnification views of elastic
fibers and microfibrillar bun-
dles. These appear less well
defined in Tsk/1 skin (d and
f) than in normal skin (c and
e). In particular, the striation
pattern of microfibrils (ar-
rowheads) seen with the nor-
mal animals (c and e) was
less apparent in the Tsk/1
mice skin. Bars: (a and b)
3,000 nm; (c–f) 250 nm.
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of the larger than normal Tsk fibrillin-1 molecules in the
abnormal microfibril pool, although the involvement of
other microfibril-associated molecules cannot be excluded
(1, 8, 9, 18, 19, 36, 39). The large microfibrillar clusters that
further distinguished the Tsk/1 skin microfibril prepara-
tions appeared to contain the abnormal microfibrils that
presumably have altered surface interactive properties.
Structural differences between morphologically normal and
abnormal Tsk/1 mice skin microfibrils were confirmed in
calcium chelation experiments in which the appearance and
periodicity of abnormal Tsk/1 skin microfibrils was funda-
mentally different from those of the morphologically nor-
mal microfibrils in these preparations. Removal of calcium
from normal microfibrils and fibrillin-1 molecules causes
molecular shortening, increased mass per unit length, and
conformational changes (16, 30, 35). Peridiocity of abnor-
mal Tsk/1 microfibrils is reduced, although the beads do
not appear prominent like those of EDTA-treated control
microfibrils; this distinct response is probably due to mis-
alignment, misfolding, or aberrant cross-linking.
The data obtained with Tsk/1 skin microfibrils show
that Tsk fibrillin-1 is produced, assembled, and deposited
Figure 4. Rotary shadowing
analysis of normal and Tsk/1
skin microfibrils. a and c, nor-
mal skin microfibrils; b and d,
Tsk/1 skin microfibrils. (a)
Normal mice skin microfibrils
exhibited well-organized pack-
ing and regular diameter. (b)
Tsk/1 mice skin microfibrils.
Some appeared normal in
morphology and periodicity,
whereas others appeared as
periodic rows of beads with in-
distinct interbeads and repeat
distances longer than normal
(arrowheads). (c) Normal mice
skin microfibrils after incuba-
tion for 10 min in 5 mM EDTA.
(d) Tsk/1 mice skin microfibrils
after incubation for 10 min in 5
mM EDTA. The apparently
normal microfibrils responded
to EDTA as control mice mi-
crofibrils, but the abnormal mi-
crofibrils remained morpho-
logically distinct (arrowheads).
Grids were examined using a
JEOL 1200EX electron micro-
scope at an accelerating volt-
age of 100 kV. Bars, 100 nm.
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in the extracellular matrix, and that abnormal beaded Tsk
fibrillin-1 microfibrils with longer than normal periodicity
and altered morphology and organization are present in
Tsk/1 skin. The experiments indicate the occurrence of
mutually exclusive normal and mutant fibrillin-1 homopoly-
meric beaded microfibrils and highlight that microfibril
periodicity directly reflects monomer length. The data
demonstrate a requirement for fibrillin molecules of simi-
lar length for copolymerization into microfibrils. The ex-
tended internal sequence of Tsk fibrillin-1 does not pre-
clude homopolymer assembly, and primary nucleation roles
for the unchanged amino- and carboxy-terminal sequences
in assembly are indicated. Molecular selection based on
length suggests that lateral alignment of fibrillin molecules
is a crucial assembly step and may precede or facilitate lin-
ear polymerization. Current models of fibrillin alignment,
based on measured molecular dimensions and antibody
epitope mapping (29), or extrapolation of molecular length
based on cbEGF-like domain dimensions (6), suggest a
parallel alignment of fibrillin monomers, although whether
the monomers are unstaggered is not resolved. The ex-
tended periodicity that results from polymerization of Tsk
fibrillin-1 molecules supports an unstaggered arrangement.
Abnormal Tsk fibrillin-1 microfibrils and aggregated clus-
ters presumably contribute to the Tsk phenotype. Muta-
tions of the human counterpart to the Fbn 1 gene, the FBN
1 locus on chromosome 15q (28), lead to a distinct pheno-
type, the Marfan syndrome (MFS), an autosomal domi-
nant disorder characterized by pleiotropic connective tissue
defects and life-threatening vascular complications. The
dominant-negative effects of MFS reflects reduced levels
of competent microfibrils in MFS patient tissues and cell
cultures (17, 28) and indicates that copolymerization of
normal and mutant allele products is universally disruptive
to microfibril structure and function. The Tsk fibrillin-1 mu-
tation may not predispose to tissue and vascular alter-
ations precisely because stable heteropolymers of both
normal and Tsk fibrillin-1 cannot form, with the normal
Figure 5. Rotary shadowing analysis
of microfibrillar aggregates isolated
from Tsk/1 skin. Numerous exten-
sive microfibril clusters were present
in the Tsk/1 skin preparations. (a and
b) Microfibril clusters after isolation
in native, calcium-containing state. (c
and d) Microfibril clusters after 10-min
incubation in 5 mM EDTA. Grids
were examined using a JEOL 1200EX
electron microscope at an accelerat-
ing voltage of 100 kV. Bars, 100 nm.
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fibrillin-1 microfibril population able to sustain normal
vascular development and functional elastic fiber formation.
Altered growth factor binding potential, either through
duplicated fibrillin-1 8-cysteine motifs or altered microfibril
association with latent transforming growth factor binding
proteins (8, 38), may contribute to the characteristic up-
regulation of extracellular matrix molecules in Tsk mice. It
is interesting to speculate that human disorders such as
congenital facial dystrophy or restrictive dermopathy (5,
39), characterized by excess collagen deposition and “tight”
skin, could have a similar aetiology to the Tsk phenotype.
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